The Biotechnology Blog
Biotechnology News
Subscribe to RSS FeedWockhardt gets USFDA nod for marketing Augmentin (Business Standard India)
Pharmaceutical and biotechnology major Wockhardt received USFDA approval for marketing and oral suspension of a combination of Amoxycillin and Clavulanate Potassium.
Final Glance: Biotechnology companies (INO News)
Amgen fell $1.13 or 2.0 percent, to $56.34. Biogen Idec fell $.42 or 1.0 percent, to $41.70.
Final Glance: Biotechnology companies (INO News)
Amgen fell $1.13 or 2.0 percent, to $56.34. Biogen Idec fell $.42 or 1.0 percent, to $41.70.
Final Glance: Biotechnology companies (INO News)
Amgen fell $1.13 or 2.0 percent, to $56.34. Biogen Idec fell $.42 or 1.0 percent, to $41.70.
Biotechnology leaders call for government support (Times Online)
British biotech has become the latest industry to plead for a government bailout as a result of the credit crisis.
Biotechnology leaders call for government support (Times Online)
British biotech has become the latest industry to plead for a government bailout as a result of the credit crisis.
Biotechnology leaders call for government support (Times Online)
British biotech has become the latest industry to plead for a government bailout as a result of the credit crisis.
Wockhardt gets USFDA nod for marketing Augmentin (Business Standard India)
Pharmaceutical and biotechnology major Wockhardt received USFDA approval for marketing and oral suspension of a combination of Amoxycillin and Clavulanate Potassium.
Wockhardt gets USFDA nod for marketing Augmentin (Business Standard India)
Pharmaceutical and biotechnology major Wockhardt received USFDA approval for marketing and oral suspension of a combination of Amoxycillin and Clavulanate Potassium.
Cowen analyst expects growth for Onyx shares (AP via Yahoo! Finance)
Biotechnology company Onyx Pharmaceuticals Inc. is likely to see its stock value grow moving into 2009 on a mix of positive cash flow and higher profit from the liver cancer drug Nexavar, according to a Cowen and Co. analyst.